Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
May 21, 2026 09:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Mar 28, 2026 03:00PM
Mar 28, 2026 03:00PM
Mar 4, 2026 08:36AM
Mar 3, 2026 10:51AM
Mar 3, 2026 07:00AM
Mar 3, 2026 07:00AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 28, 2024 09:25AM
Oct 28, 2024 09:25AM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM
Aug 8, 2024 07:00AM
May 30, 2024 07:00AM
Mar 25, 2022 08:01AM Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting
Feb 15, 2022 05:58AM
Feb 14, 2022 07:00AM
Feb 14, 2022 07:00AM
Dec 15, 2021 04:43AM

15,923 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All